Recent advances in liver-directed gene transfer vectors

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 3, 2004, Pages 332-336

  Xia, Dong ^a   Zhang, Ming Man ^a   Yan, Lu Nan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Gene therapy; Hepatocellular carcinoma; Vector

Indexed keywords

ADENOVIRUS VECTOR; ALPHA FETOPROTEIN; CALCIUM PHOSPHATE; DIETHYLNITROSAMINE; DNA; GENOMIC DNA; LENTIVIRUS VECTOR; LIPOSOME; NAKED DNA; NANOPARTICLE; PARVOVIRUS VECTOR; PLASMID DNA; RETROVIRUS VECTOR; SILICON; THYMIDINE KINASE; VIRUS PROTEIN; VIRUS VECTOR;

BACULOVIRUS; BIOENGINEERING; CANCER THERAPY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DRUG TARGETING; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; HEPATITIS VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; LIVER CELL; LIVER CELL CARCINOMA; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; MEDLINE; NONHUMAN; POXVIRUS; PROGNOSIS; PROTEIN LOCALIZATION; REVIEW; VACCINIA VIRUS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS;

EID: 4444321717     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Gerolami R, Uch R, Brechot C, Mannoni P, Bagnis C. Gene therapy of hepatocarcinoma : a long way from the concept to the therapeutic impact. Cancer Gene Ther 2003;10:649-660.
2. Alberti A, Brunetto MR, Colombo M, Craxi A. Recent progress and new trends in the treatment of hepatitis B. J Med Virol 2002;67:458-462.
3. Blum HE. Molecular therapy and prevention of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2003;2:11-22.
4. Huang XW, Lieber A, Tang ZY, Lawrence TS, Moyer MP, Zhang M. Gene expression in intrahepatic tumors through DNA recombination by a replication - activated adenovirus vector. Cancer Gene Ther 2004;11:450-456.
5. Condiotti R, Curran MA, Nolan GP, Giladi H, Ketzinel-Gilad M, Gross E, et al. Prolonged liver-specific transgene expression by a non-primate lentiviral vector. Biochem Biophys Res Commun 2004;3:998-1006.
6. Gould DJ, Favorov P. Vectors for the treatment of autoimmune disease. Gene Ther 2003;10:912-927.
7. Tsujinoue H, Kuriyama S, Nakatani T, Yoshiji H, Akahane T, Toyokawa Y, et al. Amelioration of retrovirus-mediated gene transfer into hepatocellular carcinoma cells. Int J Oncol 2001;18: 801-807.
8. Ye P, Thompson AR, Sarkar R, Shen Z, Lillicrap DP, Kaufman RJ, et al. Naked DNA transfer of factor VIII induced transgene-specific, species - independent immune response in hemophilia a mice. Mol Ther 2004;10:117-126.
9. Miao CH, Ye X, Thompson AR. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors. Hum Gene Ther 2003;14:1297-1305.
10. Barlet MP, Pichard V, Ferry N. Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology 2002;36:623-630.
11. Ovejero C, Cavard C, Perianin A, Hakvoort T, Vermeulen J, Godard C, et al. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology 2004;40:167-176.
12. Bilbao R, Gerolami R, Bralet AMP, Qian C, Tran PL, Tennant B. Transduction efficacy, antitumoral and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model. Cancer Gene Ther 2000;7:657-662.
13. Takahashi M, Sato T, Sagawa T, Lu Y, Sato Y, Iyama S, et al. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor. Mol Ther 2002;5:627-634.
14. Tomizawa M, Yu L, Wada A, Tamaoki T, Kadomatsu K, Muramatsu T, et al. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Br J Cancer 2003;89:1086-1090.
15. Ninomiya T, Mihara K, Fushimi K, Hayashi Y, Hashimoto-Tamaoki T, Tamaoki T. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma. Hepatology 2002;35:82-87.
16. Wang L, Hernandez-Alcoceba R, Shankar V, Zabala M, Kochanek S, Sangro B, et al. Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer. Gastroenterology 2004;126: 278-289.
17. Peng D, Qian C, Sun Y, Barajas MA, Prieto J. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated vinis (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol 2000;32:975-985.
18. Gerolami R, Uch R, Faivre J, Garcia S, Hardwigsen J, Cardoso J, et al. Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors. J Hepatol 2004;40:291-297.
19. Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, et al. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma. Cancer Gene Ther 2003;10:260-269.
20. Gao LF, Sun WS, Ma CH, Liu SX, Wang XY, Zhang LN, et al. Establishment of mice model with human viral hepatitis B. World J Gastroenterol 2004;10:841-846.
21. Yang RY, Zeng QP, Fu LC, Chen ZT. Evaluation on expression of the recombinant S gene of human hepatitis B virus in vitro and in vivo. Hepatobiliary Pancreat Dis Int 2003;2:259-264.
22. Lu YY, Li K, Cheng J, Wang L, Liu Y, Zhang LX. Cloning and expression of the preS1 gene of hepatitis B virus in yeast cells. Hepatobiliary Pancreat Dis Int 2002; 1:238-242.
23. Tsui LV, Kelly M, Zayek N, Rojas V, Ho K, Ge Y, et al. Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat Biotechnol 2002; 20:53-57.
24. Kowolik CM, Yee JK. Preferential transduction of human hepatocytes with lentiviral vectors pseudotyped by Sendai virus F protein: Mol Ther 2002;5:762-769.
25. Follenzi A, Gupta S. The promise of lentiviral gene therapy for liver cancer. J Hepatol 2004;40:337-340.
26. Mullen JT, Tanabe KK. Viral oncolysis for malignant liver tumors. Ann Surg Oncol 2003;10:596-605.
27. Kasuya H, Pawlik TM, Mullen JT, Donahue JM, Nakamura H, Chandrasekhar S, et al. Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen. Cancer Res 2004;64:2561-2567.
28. Grimm CF, Ortmann D, Mohr L, Michalak S, Krohne TU, Meckel S, et al. Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 2000;119:1104-1112.
29. Gnant MF, Noll LA, Irvine KR, Puhlmann M, Terrill RE, Alexander HR Jr, et al. Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of Ever metastases. J Natl Cancer Inst 1999;91:1744-1750.
30. Park SW, Lee HK, Kim TG, Yoon SK, Paik SY. Hepatocyte-specific gene expression by baculovinis pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochem Biophys Res Commun 2001;289:444-450.
31. Yoshida M, Yamamoto N, Uehara T, Terao R, Nitta T, Harada N, et al. Kupffer cell targeting by intraportal injection of the HVJ cationic liposome. Eur Surg Res 2002; 34:251-259.
32. Cho CW, Cho YS, Lee HK, Yeom YI, Park SN, Yoon DY. Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent. Biotechnol Appl Biochem 2000;32:21-26.
33. Li YZ, Wang Q, Jiang YF. Establishment of hepatocarcinoma cell line transfected by the B7 gene and its biocharacteristics. Hepatobitiary Pancreat Dis Int 2003;2:278-280.
34. Sun XY, Wu ZD, Hu JB. Suicide gene therapy of hepatocellular carcinoma and delivery procedure and route of therapeutic gene in vivo. Hepatobiliary Pancreat Dis Int 2002;1:373-377.
35. Onishi T, Nouso K, Higashi T, Toshikuni N, Nakatsukasa H, Kobayashi Y, et al. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. J Gastroenterol Hepatol 2003;18:1168-1174.
36. Roy I, Mitra S, Maitra A, Mozumdar S. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int J Pharm 2003;250:25-33.
37. Chen Y, Xue Z, Zheng D, Xia K, Zhao Y, Liu T, et al. Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. Curr Gene Ther 2003;3:273-279.